WM-Therapeutics is founded in 2020, operates from its headquarter in Waldhofer Str. 104 Heidelberg, Germany 69123, DE. The company operates in the Hospitals & Healthcare, Medical Practices sector.
WM-Therapeutics specializes in Proteotoxic stress response, UPR (Unfolded Protein Response), Cancer cell metabolism, Tumor autonomous growth inhibition, Immune system stimulation, Small molecule therapy development, and offers services including Targeted chemotherapy, Immunooncology approach, and Single small molecule therapy.